切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2025, Vol. 14 ›› Issue (03) : 133 -138. doi: 10.3877/cma.j.issn.2095-3259.2025.03.002

降低产科出血改善不良妊娠结局

严重产后出血与凝血功能障碍
竺洁, 熊钰()   
  1. 200090 上海,复旦大学附属妇产科医院产科
  • 收稿日期:2024-11-21 出版日期:2025-08-18
  • 通信作者: 熊钰
  • 基金资助:
    上海市科委"科技创新行动计划"医学创新研究专项(21Y11908000); 上海申康医院发展中心第二轮〈促进市级医院临床技能与临床创新三年行动计划(2023-2025年)〉(SHDC2024CRI001)

Severe postpartum hemorrhage and coagulopathy

Jie Zhu, Yu Xiong()   

  • Received:2024-11-21 Published:2025-08-18
  • Corresponding author: Yu Xiong
引用本文:

竺洁, 熊钰. 严重产后出血与凝血功能障碍[J/OL]. 中华产科急救电子杂志, 2025, 14(03): 133-138.

Jie Zhu, Yu Xiong. Severe postpartum hemorrhage and coagulopathy[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2025, 14(03): 133-138.

严重产后出血是导致孕产妇死亡或脏器损伤的主要原因。严重产后出血合并凝血功能障碍更是增加了病情的复杂性和凶险性,对母儿结局产生极为不利的影响。文章就严重产后出血凝血功能障碍的发病机制、预防策略、诊断方法以及处理措施进行阐述,旨在为提高产科医疗质量、降低孕产妇死亡率提供理论指导。

Severe postpartum hemorrhage (SPPH) is the main cause of maternal mortality or organ damage in pregnant women. SPPH combined with coagulation dysfunction increases the complexity and peril of the condition, exerting profoundly adverse effects on maternal and neonatal outcomes. This article elaborates on the pathogenesis, prevention strategies, diagnostic methods, and management measures of SPPH with coagulation dysfunction, aiming to provide academic guidance for enhancing the quality of obstetric care and reducing maternal mortality.

[1]
Chandraharan E, Krishna A. Diagnosis and management of postpartum haemorrhage[J]. BMJ2017358:j3875.
[2]
Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage: green-top guideline No. 52[J]. BJOG, 2017124(5):e106-149.
[3]
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage.[M/OL] Geneva: World Health Organization,2012[2024-11-21].

URL    
[4]
周莉,范玲. 妊娠期凝血功能特点[J/OL]. 中华产科急救电子杂志20143(2): 81-85.
[5]
Rigouzzo A, Louvet N, Favier R, et al. Assessment of coagulation by thromboelastography during ongoing postpartum hemorrhage: a retrospective cohort analysis[J]. Anesth Analg2020130(2):416-425.
[6]
Liu J, Yuan E, Lee L. Gestational age-specific reference intervals for routine haemostatic assays during normal pregnancy[J]. Clin Chim Acta2012413(1-2):258-261.
[7]
李丹,何志晖. 严重产后出血及与其相关的子宫切除危险因素分析[J/OL]. 中华产科急救电子杂志2021(4):220-224.
[8]
Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage[J]. J Thromb Haemost20075(2): 266-273.
[9]
Wikkelsø A, Wetterslev J, Møller AM, et al. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding[J]. Cochrane Database Syst Rev2016(8):CD007871.
[10]
Girard T, Mörtl M, Schlembach D. New approaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm[J]. Curr Opin Anaesthesiol201427(3):267-274.
[11]
Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management[J]. Br J Anaesth2012109(6):851-863.
[12]
de Lange NM, Lancé MD, de Groot R, et al. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage[J]. Obstet Gynecol Surv201267(7):426-435.
[13]
Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: developing a thrombelastography®-guided transfusion algorithm[J]. Anaesth Intensive Care201240(6): 1007-1015.
[14]
Koyama K, Madoiwa S, Nunomiya S, et al. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study[J]. Crit Care201418(1):R13.
[15]
Mei H, Jiang Y, Luo L, et al. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: a multi-center prospective observational study[J]. Thromb Res2019173:20-26.
[16]
Takano S, Kimura S, Ohdama S, et al. Plasma thrombomodulin in health and diseases[J]. Blood199076(10):2024-2029.
[17]
Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition[J]. Crit Care201923(1):98.
[18]
中华医学会围产医学分会,中国输血协会临床输血管理学专业委员会. 产科输血治疗专家共识[J]. 中华围产医学杂志2023(1):4-10.
[19]
Escobar MF, Nassar AH, Theron G, et al. FIGO recommendations on the management of postpartum hemorrhage 2022[J]. Int J Gynaecol Obstet2022157 Suppl 1:3-50.
[20]
Hunt BJ, Allard S, Keeling D, et al. A practical guideline for the haematological management of major haemorrhage[J]. Br J Haematol2015170(6):788-803.
[21]
Collins P, Abdul-Kadir R, Thachil J, et al. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH[J]. J Thromb Haemost201614(1):205-210.
[22]
Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016[J]. Eur J Anaesthesiol201734(6):332-395.
[23]
中华医学会妇产科学分会产科学组,中华医学会围产医学分会. 产后出血预防与处理指南(2023)[J]. 中华妇产科杂志202358(6): 401-409.
[24]
Chowdary P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients[J]. Br J Haematol2004125(1):69-73.
[25]
Muñoz M, Stensballe J, Ducloy-Bouthors AS, et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement[J]. Blood Transfus201917(2):112-136.
[26]
El-Hamamy E, Wright A, B-Lynch C. The B-Lynch suture technique for postpartum haemorrhage: a decade of experience and outcome[J]. J Obstet Gynaecol200929(4):278-283.
[27]
Sentilhes L, Kayem G, Chandraharan E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management[J]. Int J Gynaecol Obstet2018140(3):291-298.
[28]
Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage[J]. Cochrane Database Syst Rev2015(6):CD007872.
[29]
Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial[J]. Lancet2017389(10084):2105-2116.
[30]
Colucci G, Helsing K, Biasiutti FD, et al. Standardized management protocol in severe postpartum hemorrhage: a single-center study[J]. Clin Appl Thromb Hemost201824(6):884-893.
[1] 刘振清, 黄莉, 王帅, 谢晨欣, 刘鸿圣. 胎盘MRI评分联合临床特征对胎盘植入性疾病孕妇产后出血的预测价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(01): 37-43.
[2] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[3] 李霞林, 贺芳. 产后出血风险评估和早期预警系统[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 498-503.
[4] 李小飞, 刘洪莉, 石丘玲, 田静, 李莉, 漆洪波, 罗欣. 自然分娩产妇低强度聚焦超声子宫复旧治疗防治产后出血的前瞻性随机对照研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 534-539.
[5] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[6] 陈莉, 雷雪芹, 段炼, 曾悦, 何国琳. 影响2次剖宫产术后阴道试产产妇试产成功因素及妊娠结局分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 287-294.
[7] 张丽娜, 谌楚宇, 杨新宇, 邱海波, 吕奔. 脓毒症凝血功能障碍:2024 年度进展与展望[J/OL]. 中华重症医学电子杂志, 2025, 11(02): 105-111.
[8] 李世明, 黄蔚, 刘玲. HMGB1介导脓毒症相关凝血功能障碍的作用机制及其治疗进展[J/OL]. 中华重症医学电子杂志, 2023, 09(03): 269-273.
[9] 雷雨钦, 王晓怡. 通过模拟培训提高医护人员对严重产后出血的救治能力[J/OL]. 中华产科急救电子杂志, 2025, 14(02): 80-85.
[10] 付以琳, 丁文成. 严重产后出血容量复苏[J/OL]. 中华产科急救电子杂志, 2025, 14(02): 75-79.
[11] 周玮. 严重产后出血的早识别[J/OL]. 中华产科急救电子杂志, 2025, 14(02): 70-74.
[12] 叶湘云, 麻希洋, 贺芳. 产后大出血合并肺出血一例并文献复习[J/OL]. 中华产科急救电子杂志, 2025, 14(01): 46-53.
[13] 王永, 李霞林, 杨蓉, 潘康妮, 余琳, 王伟伟, 孙雯, 陈敦金. 胎盘植入合并严重产后出血输血方案的研究[J/OL]. 中华产科急救电子杂志, 2023, 12(03): 173-179.
[14] 赵先兰, 周艳. 胎盘植入性疾病出血血管介入治疗策略[J/OL]. 中华产科急救电子杂志, 2023, 12(03): 147-150.
[15] 吕丽爱, 赖林强, 张登科. 罕见髂外动脉起源子宫动脉相关的产后出血一例[J/OL]. 中华介入放射学电子杂志, 2025, 13(02): 190-192.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?